[Chinese expert consensus on diagnosis and treatment of short bowel syndrome in adults (2026 version)].

Developed by the Parenteral and Enteral Nutrition Professional Committee of the Chinese Research Hospital Association, the expert consensus on the diagnosis and treatment of short bowel syndrome in adults (2026 version) aims to update and standardize the clinical management of adult short bowel syndrome (SBS) in China. Based on the latest domestic and international evidence, recommendations were evaluated using the GRADE system and finalized through expert voting. This document comprehensively delineates the definition, diagnostic classification, pathophysiological staging, and severity assessment of SBS. It systematically details treatment strategies designed to promote intestinal rehabilitation and minimize complications, encompassing multidisciplinary team (MDT) management, individualized nutritional support (parenteral and enteral nutrition), pharmacotherapy (e.g., glucagon-like peptide-2), non-transplant surgery, and intestinal transplantation. Furthermore, specific recommendations address the prevention and management of common complications, including cholestasis, renal insufficiency, and metabolic bone disease. By emphasizing the importance of long-term follow-up and patient education, this consensus serves as a vital reference for standardized SBS care, ultimately aiming to improve patient quality of life and clinical outcomes.